Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve …
IM Svane, EM Verdegaal - Cancer immunology, immunotherapy, 2014 - Springer
Adoptive cell therapy (ACT) based on autologous T cell derived either from tumor as tumor-
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
[引用][C] Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to …
IM Svane, EM Verdegaal - Cancer …, 2014 - scholarlypublications …
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived
lymphocytes for metastatic melanoma: what is needed to achieve standard of care …
lymphocytes for metastatic melanoma: what is needed to achieve standard of care …
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve …
I Svane, E Verdegaal - Cancer Immunology, Immunotherapy, 2014 - search.ebscohost.com
Adoptive cell therapy (ACT) based on autologous T cell derived either from tumor as tumor-
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve …
IM Svane, EM Verdegaal - Cancer Immunology, Immunotherapy: CII, 2014 - europepmc.org
Adoptive cell therapy (ACT) based on autologous T cell derived either from tumor as tumor-
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve …
IM Svane, EM Verdegaal - Cancer Immunology …, 2014 - search.proquest.com
Adoptive cell therapy (ACT) based on autologous T cell derived either from tumor as tumor-
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve …
IM Svane, EM Verdegaal - Cancer immunology …, 2014 - research.regionh.dk
Adoptive cell therapy (ACT) based on autologous T cell derived either from tumor as tumor-
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve …
IM Svane, EM Verdegaal - Cancer immunology …, 2014 - pubmed.ncbi.nlm.nih.gov
Adoptive cell therapy (ACT) based on autologous T cell derived either from tumor as tumor-
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve …
IM Svane, EM Verdegaal - Cancer Immunology, Immunotherapy, 2014 - infona.pl
Adoptive cell therapy (ACT) based on autologous T cell derived either from tumor as tumor-
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
[引用][C] Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to …
Cancer immunology, immunotherapy: CII, 2014 - core.ku.dk
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived
lymphocytes for metastatic melanoma - Fitmum: Fitness for good health of mother and child …
lymphocytes for metastatic melanoma - Fitmum: Fitness for good health of mother and child …
[HTML][HTML] Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to …
IM Svane, EM Verdegaal - Cancer Immunology, Immunotherapy …, 2014 - ncbi.nlm.nih.gov
Adoptive cell therapy (ACT) based on autologous T cell derived either from tumor as tumor-
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …
infiltrating lymphocytes (TILs) or from peripheral blood is developing as a key area of future …